UA29476C2 - Трансдермальна терапевтична система, що містить естрадіол - Google Patents

Трансдермальна терапевтична система, що містить естрадіол

Info

Publication number
UA29476C2
UA29476C2 UA95114785A UA95114785A UA29476C2 UA 29476 C2 UA29476 C2 UA 29476C2 UA 95114785 A UA95114785 A UA 95114785A UA 95114785 A UA95114785 A UA 95114785A UA 29476 C2 UA29476 C2 UA 29476C2
Authority
UA
Ukraine
Prior art keywords
transdermal therapeutic
therapeutic system
containing estradiol
estradiol
production
Prior art date
Application number
UA95114785A
Other languages
English (en)
Russian (ru)
Inventor
Рейнболд Меконі
Рейнболд Мекони
Франк Зайбертц
Міхаель Хорстманн
Михаель ХОРСТМАНН
Райнер Ліхтенбергер
Райнер Лихтенбергер
Original Assignee
Лтс Ломанн Терапі-Зюстеме Гмбх Унд Ко. Кг
ЛТС Ломанн Терапи-Зюстеме ГмбХ унд Ко. КГ
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лтс Ломанн Терапі-Зюстеме Гмбх Унд Ко. Кг, ЛТС Ломанн Терапи-Зюстеме ГмбХ унд Ко. КГ, Мерк Патент Гмбх filed Critical Лтс Ломанн Терапі-Зюстеме Гмбх Унд Ко. Кг
Publication of UA29476C2 publication Critical patent/UA29476C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Abstract

Винахід стосується трансдермальної терапевтичної системи для контрольованого введення естрадіолу або його фармацевтично прийнятних похідних і способу її приготування.
UA95114785A 1993-05-06 1994-04-25 Трансдермальна терапевтична система, що містить естрадіол UA29476C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4314970 1993-05-06
DE4336557A DE4336557C2 (de) 1993-05-06 1993-10-27 Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
PCT/EP1994/001279 WO1994026257A1 (de) 1993-05-06 1994-04-25 Estradiolhaltiges transdermales therapeutisches system

Publications (1)

Publication Number Publication Date
UA29476C2 true UA29476C2 (uk) 2000-11-15

Family

ID=25925640

Family Applications (1)

Application Number Title Priority Date Filing Date
UA95114785A UA29476C2 (uk) 1993-05-06 1994-04-25 Трансдермальна терапевтична система, що містить естрадіол

Country Status (28)

Country Link
US (2) US6143319A (uk)
EP (1) EP0697860B1 (uk)
JP (1) JP3885233B2 (uk)
KR (1) KR100343877B1 (uk)
CN (1) CN1136843C (uk)
AT (1) ATE196843T1 (uk)
AU (1) AU696816B2 (uk)
CA (1) CA2160775C (uk)
CZ (1) CZ291656B6 (uk)
DE (2) DE4336557C2 (uk)
DK (1) DK0697860T3 (uk)
ES (1) ES2152979T3 (uk)
FI (1) FI115034B (uk)
GR (1) GR3035200T3 (uk)
HU (1) HU221166B1 (uk)
IL (1) IL109508A (uk)
MX (1) MXPA94003365A (uk)
MY (1) MY111515A (uk)
NO (1) NO309891B1 (uk)
NZ (1) NZ266140A (uk)
PL (1) PL179962B1 (uk)
PT (1) PT697860E (uk)
RU (1) RU2140784C1 (uk)
SI (1) SI0697860T1 (uk)
SK (1) SK282230B6 (uk)
TW (1) TW382599B (uk)
UA (1) UA29476C2 (uk)
WO (1) WO1994026257A1 (uk)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US9314527B2 (en) 2010-03-30 2016-04-19 Phosphagenics Limited Transdermal delivery patch
US10188670B2 (en) 2011-03-15 2019-01-29 Phosphagenics Limited Composition
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
US11753435B2 (en) 2016-12-21 2023-09-12 Avecho Biotechnology Limited Process

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
AU719171B2 (en) * 1995-01-14 2000-05-04 Abbott Laboratories A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung
DE19713141A1 (de) * 1996-03-29 1997-10-30 Labtec Gmbh Transdermales System mit Melatonin
DE19828273B4 (de) 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
KR100638150B1 (ko) 1998-12-23 2006-10-26 이데아 악티엔게젤샤프트 생체내에서 국부적인 비침습성 용도로 사용되는 개선된 제제
SI1031347T1 (en) 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
DK1031346T3 (da) 1999-01-27 2002-08-12 Idea Ag Ikke-invasiv vaccination gennem huden
CA2299950C (en) * 1999-03-03 2010-09-21 Nitto Denko Corporation Oral adhesive sheet and oral adhesive preparation
IL147247A0 (en) 1999-07-02 2002-08-14 Lohmann Therapie Syst Lts Microreservoir system based on polysiloxanes and ambiphilic solvents
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
BRPI0015939B8 (pt) * 1999-11-29 2021-05-25 Lts Lohmann Therapie Systeme Ag sistema terapêutico transdérmico com estabilidade aperfeiçoada e processo para a sua preparação
DE10054713C2 (de) * 1999-11-29 2002-07-18 Lohmann Therapie Syst Lts Transdermale Therapeutische Systeme mit verbesserter Stabilität und ein Verfahren zu ihrer Herstellung
WO2001052823A2 (en) 2000-01-20 2001-07-26 Noven Pharmaceuticals, Inc. Compositions to effect the release profile in the transdermal administration of drugs
ES2367541T3 (es) * 2000-04-18 2011-11-04 Hisamitsu Pharmaceutical Co., Inc. Parche que contiene un agente antiinflamatorio.
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
ATE526973T1 (de) * 2001-06-18 2011-10-15 Noven Pharma Verbesserte arzneimittelabgabe in transdermalen systemen
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US8435942B2 (en) * 2002-05-31 2013-05-07 Transdermal Biotechnology, Inc. Methods for formulating stabilized insulin compositions
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
SI1594483T1 (sl) * 2003-02-21 2006-12-31 Schering Ag UV-stabilni transdermalni terapevtski obliz
UA89766C2 (en) 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US20080269121A1 (en) * 2005-02-25 2008-10-30 The Board Of Regents Of The University Of Texas System Methods and Compositions Involving A1c Subunit of L-Type Calcium Channels in Smooth Muscle Cells
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US20070258935A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water dispersible films for delivery of active agents to the epidermis
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
RS55681B1 (sr) 2010-09-06 2017-07-31 Bayer Ip Gmbh Transdermalni flasteri sa malom dozom i velikim oslobađanjem leka
WO2012125214A1 (en) 2011-03-17 2012-09-20 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8871245B2 (en) * 2012-02-28 2014-10-28 Nichiban Co., Ltd. Transdermal patch
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
CN104546804A (zh) * 2013-10-09 2015-04-29 上海现代药物制剂工程研究中心有限公司 三维网状立体构型的透皮给药制剂及其制备方法
EP2921184A1 (de) * 2014-03-19 2015-09-23 LTS LOHMANN Therapie-Systeme AG Überpflaster mit verbesserter Verträglichkeit und einer langen Haftungsdauer und Verfahren zu seiner Herstellung
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
CN104840449B (zh) * 2015-04-22 2018-05-18 崔建平 一种药物贴剂及其制备方法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
RU2648470C2 (ru) * 2016-03-03 2018-03-26 Государственное бюджетное образовательное учреждение высшего профессионального образования "Уральский государственный медицинский университет Министерства здравоохранения Российской Федерации" (ГБОУ ВПО УГМУ Минздрава России) Способ оптимизации лечения женщин кардиотропной терапией и заместительной гормональной терапией при эстрогенодефиците с артериальной гипертензией в позднем репродуктивном периоде
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637224A (en) * 1969-02-27 1972-01-25 Fedders Corp Annular sealing ring
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
AU553343B2 (en) * 1981-08-10 1986-07-10 Advance Electrode Kabushikikaisya Absorbent adhesive bandage with medicament release
KR970009886B1 (ko) * 1981-08-30 1997-06-19 히사미쯔세이야꾸 가부시기가이샤 소염진통 첩부제
US4624665A (en) * 1984-10-01 1986-11-25 Biotek, Inc. Method of transdermal drug delivery
EP0186019B1 (de) * 1984-12-22 1993-10-06 Schwarz Pharma Ag Wirkstoffpflaster
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
CH674618A5 (uk) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991017752A1 (fr) * 1990-05-17 1991-11-28 Hisamitsu Pharmaceutical Co., Inc. Preparation a administration percutanee, contenant de l'×stradiol
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
DE4223360C1 (uk) * 1992-07-16 1993-04-08 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5928666A (en) * 1996-11-12 1999-07-27 Cygnus Inc. Crystalline form of estradiol and pharmaceutical formulations comprising same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9168216B2 (en) 2005-06-17 2015-10-27 Vital Health Sciences Pty. Ltd. Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US9314527B2 (en) 2010-03-30 2016-04-19 Phosphagenics Limited Transdermal delivery patch
US10188670B2 (en) 2011-03-15 2019-01-29 Phosphagenics Limited Composition
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
US11753435B2 (en) 2016-12-21 2023-09-12 Avecho Biotechnology Limited Process

Also Published As

Publication number Publication date
AU6721394A (en) 1994-12-12
CZ289295A3 (en) 1996-08-14
CZ291656B6 (cs) 2003-04-16
US6143319A (en) 2000-11-07
IL109508A0 (en) 1994-08-26
ATE196843T1 (de) 2000-10-15
AU696816B2 (en) 1998-09-17
MY111515A (en) 2000-07-31
SI0697860T1 (en) 2001-02-28
IL109508A (en) 1998-10-30
KR100343877B1 (ko) 2002-12-05
KR960702300A (ko) 1996-04-27
DE4336557C2 (de) 1997-07-17
HU9503168D0 (en) 1996-01-29
PL179962B1 (pl) 2000-11-30
MXPA94003365A (es) 2005-03-09
CN1136843C (zh) 2004-02-04
CA2160775A1 (en) 1994-11-24
RU2140784C1 (ru) 1999-11-10
DK0697860T3 (da) 2001-02-05
EP0697860B1 (de) 2000-10-11
SK282230B6 (sk) 2001-12-03
NO954413D0 (no) 1995-11-03
CA2160775C (en) 2006-06-06
FI115034B (fi) 2005-02-28
ES2152979T3 (es) 2001-02-16
US6521250B2 (en) 2003-02-18
GR3035200T3 (en) 2001-04-30
NO954413L (no) 1995-11-03
NZ266140A (en) 1997-09-22
FI955259A0 (fi) 1995-11-02
HU221166B1 (en) 2002-08-28
DE59409548D1 (de) 2000-11-16
TW382599B (en) 2000-02-21
NO309891B1 (no) 2001-04-17
WO1994026257A1 (de) 1994-11-24
DE4336557A1 (de) 1994-11-10
EP0697860A1 (de) 1996-02-28
PT697860E (pt) 2001-03-30
SK137995A3 (en) 1997-02-05
HUT73847A (en) 1996-09-30
JP3885233B2 (ja) 2007-02-21
FI955259A (fi) 1995-11-30
PL311590A1 (en) 1996-02-19
CN1122569A (zh) 1996-05-15
US20020012691A1 (en) 2002-01-31
JPH08509748A (ja) 1996-10-15

Similar Documents

Publication Publication Date Title
UA29476C2 (uk) Трансдермальна терапевтична система, що містить естрадіол
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
MY104065A (en) New pharmaceutical preparation
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
BG102200A (en) Transcorneal system for the release of a medicament
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
HU9402238D0 (en) 1-benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, process for producing them and pharmaceutical compositions containing them
PL326322A1 (en) Ciral methylphenyloxyazolydinones
PL317830A1 (en) Derivatives of a sterol used for controlling meiosis
UA41355C2 (uk) Засіб для лікування нейро-сніду
WO1993000094A3 (en) Use of tetrahydrobenzazepine derivatives for the treatment of portal hypertension and migraine
MY129130A (en) (+)-norcisapride
GB9212308D0 (en) Therapeutic compositions
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU4891590A (en) A process for the treatment of material-gas mixtures
ZA963743B (en) Transdermal therapeutic system (TTS) for the administration of testosterone
HUP9602640A2 (en) Substituted benzoyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them and the use of the compds.
HU9303376D0 (en) Process for producing alpha, omega-diaryl-alkane derivatives and pharmaceutical compositions containing them
AU3189989A (en) Process for the treatment of concrete
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
DK162889A (da) Fremgangsmaade til rensning af dipeptider
IL96506A0 (en) Transdermal system for administering pharmaceutical compounds under ph control
AU4288796A (en) Novel processes for preparing ranitidine
ZA966083B (en) Agent for transdermal administration containing esters of 13-ethyl-17ß-hydroxy-11-methylene-18,19-dinor-17Ó-pregn-4-en-20-yn-3-one.
EP0599658A3 (en) Process for the preparation of 6-beta, 14-alpha-dihydroxy-4-androstene-3,17-dione.